📰 Roche Diagnostics Communications News
Roche Diagnostics Communications News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roche Diagnostics Communications. Real-time updates on events, politics, business and more.
May 17, 2023
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will be showcasing innovative laboratory solutions and digital diagnostics through -...
May 17, 2023
Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will introduce navify® digital solutions that help laboratories
March 6, 2023
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA PD-L1 (SP263)...
February 9, 2023
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create...
November 15, 2022
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay,...
October 3, 2022
The SARS-CoV-2 Rapid Antibody Test 2.0 is configured for broader use by healthcare professionals to now include vaccinated individuals, in addition to those...
September 9, 2022
The VENTANA PD-L1 (SP263) Assay helps determine which patients with non-small cell lung cancer may be eligible for treatment with Libtayo monotherapy1 based on...
August 24, 2022
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC)...
August 11, 2022
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx...
April 5, 2022
New diagnostics solutions will be presented that help clinicians improve patient care and support healthcare systems. Participants can join virtually or onsite...